Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-25 @ 5:01 AM
NCT ID:
NCT03381118
Eligibility Criteria:
Inclusion Criteria:
* Patients with a diagnosis of acute myeloid leukemia with the confirmed first or second complete remission
* ≥ 55 years of age
* Not candidates for allogeneic stem cell transplantation as decided by the panel of hematologists at the transplant center
* Patients with a HLA-haploidentical donor who should be able to provide informed consent for peripheral blood apheresis
* No severe concurrent illness that limits life expectancy to less than 2 years
Exclusion Criteria:
* Uncontrolled bacterial or fungal infection at the time of enrollment
* Karnofsky index \<70%
* Acute promyelocytic leukemia
* Other tumor requiring treatment at the time of enrollment
* Active or prior documented autoimmune disease requiring systemic treatment
* Somatic or psychiatric disorder making the patient unable to sign informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
55 Years
Maximum Age:
85 Years
Study:
NCT03381118
Study Brief:
Protocol Section:
NCT03381118